Importantly, accumulation of intraneuronal Aβ and phosphorylated tau in the basolateral amygdala seems to contribute to these symptoms6, whereas Se treatment causes a slight non-significant reduction in tau pathology in this region in 3xTg-AD mice (Table 1). The gene discussed is MAPT; the disease is Alzheimer disease.